In a study of Medicare beneficiaries, researchers from Brigham and Women’s Hospital found that one year after hospitalization for heart failure, 6 percent of patients had progressed to dialysis.
FDA approves study of Versameb’s mRNA therapy in urinary incontinence – Pharmaceutical Technology
Share this article The Phase IIa study of the mRNA treatment is scheduled to start in the first half of 2024. Credit: valiantsin suprunovich via